FDA committee questions Fluosol efficacy; US approval not imminent.
D001802:Blood Substitutes; D004338:Drug Combinations; D005466:Fluorocarbons; D006801:Humans; D006895:Hydroxyethyl Starch Derivatives; D007880:Legislation, Drug; D014481:United States; D014486:United States Food and Drug Administration
D001802:Blood Substitutes; D004338:Drug Combinations; D005466:Fluorocarbons; D006895:Hydroxyethyl Starch Derivatives; C017323:glucose, glycerol, hydroxyethyl starch, perfluorodecalin, perfluorotripropylamine, pluronic F-68, salts, yolk phospholipids drug combination